J.P. Morgan Day 2: Pharma Offers (Some) Views On Drug Pricing Reform
Updates From Pfizer, Merck & Co., AbbVie, Novartis, Sanofi, Biogen
Daily round-up from the virtual J.P. Morgan Healthcare Conference: Novartis explains its PD-1 deal; Biogen partners with Apple; Sanofi and Merck discuss business development priorities; and why AbbVie is confident it can grow without relying on deals.
